Effect of combined zidovudine and didanosine therapy in early asymptomatic primary HIV-1 infection.
Khajotia
R R
RR
Feigley
C E
CE
Lee
E
E
Gu
J
J
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D016049:Didanosine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D016655:HIV Core Protein p24 / Q000097:blood; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D015497:HIV-1; D006801:Humans; D016133:Polymerase Chain Reaction; D016896:Treatment Outcome; D015215:Zidovudine / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D016655:HIV Core Protein p24; D015215:Zidovudine; D016049:Didanosine